BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

237 related articles for article (PubMed ID: 23151828)

  • 1. Evaluation of adrenal metastases from renal cell carcinoma and hepatocellular carcinoma: use of delayed contrast-enhanced CT.
    Choi YA; Kim CK; Park BK; Kim B
    Radiology; 2013 Feb; 266(2):514-20. PubMed ID: 23151828
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adrenal adenoma and metastasis from clear cell renal cell carcinoma: can they be differentiated using standard MR techniques?
    Woo S; Cho JY; Kim SY; Kim SH
    Acta Radiol; 2014 Nov; 55(9):1120-8. PubMed ID: 24252816
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adrenocortical carcinomas and adrenal pheochromocytomas: mass and enhancement loss evaluation at delayed contrast-enhanced CT.
    Szolar DH; Korobkin M; Reittner P; Berghold A; Bauernhofer T; Trummer H; Schoellnast H; Preidler KW; Samonigg H
    Radiology; 2005 Feb; 234(2):479-85. PubMed ID: 15671003
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adenoma characterization: adrenal protocol with dual-energy CT.
    Kim YK; Park BK; Kim CK; Park SY
    Radiology; 2013 Apr; 267(1):155-63. PubMed ID: 23329655
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diagnostic performance of hepatic CT and chemical-shift MRI to discriminate lipid-poor adrenal adenomas from hepatocellular carcinoma metastases.
    Nagayama Y; Hayashi H; Taguchi N; Yoshida R; Harai R; Kidoh M; Oda S; Nakaura T; Hirai T
    Abdom Radiol (NY); 2024 May; 49(5):1626-1637. PubMed ID: 38456897
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Incidental adrenal lesions: accuracy of characterization with contrast-enhanced washout multidetector CT--10-minute delayed imaging protocol revisited in a large patient cohort.
    Sangwaiya MJ; Boland GW; Cronin CG; Blake MA; Halpern EF; Hahn PF
    Radiology; 2010 Aug; 256(2):504-10. PubMed ID: 20656838
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of delayed enhanced CT and chemical shift MR for evaluating hyperattenuating incidental adrenal masses.
    Park BK; Kim CK; Kim B; Lee JH
    Radiology; 2007 Jun; 243(3):760-5. PubMed ID: 17517932
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Distinguishing benign from malignant adrenal masses: multi-detector row CT protocol with 10-minute delay.
    Blake MA; Kalra MK; Sweeney AT; Lucey BC; Maher MM; Sahani DV; Halpern EF; Mueller PR; Hahn PF; Boland GW
    Radiology; 2006 Feb; 238(2):578-85. PubMed ID: 16371582
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differentiation of Adrenal Hyperplasia From Adenoma by Use of CT Densitometry and Percentage Washout.
    Park SY; Park BK; Park JJ; Kim CK
    AJR Am J Roentgenol; 2016 Jan; 206(1):106-12. PubMed ID: 26700341
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adrenal adenomas and nonadenomas: assessment of washout at delayed contrast-enhanced CT.
    Szolar DH; Kammerhuber FH
    Radiology; 1998 May; 207(2):369-75. PubMed ID: 9577483
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Distinguishing adrenal adenomas from non-adenomas with multidetector CT: evaluation of percentage washout values at a short time delay triphasic enhanced CT.
    Liu T; Sun H; Zhang H; Duan J; Hu Y; Xie S
    Br J Radiol; 2019 Feb; 92(1094):20180429. PubMed ID: 30433826
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Delayed enhanced CT of lipid-poor adrenal adenomas.
    Caoili EM; Korobkin M; Francis IR; Cohan RH; Dunnick NR
    AJR Am J Roentgenol; 2000 Nov; 175(5):1411-5. PubMed ID: 11044054
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Distinguishing adrenal adenomas from non-adenomas on dynamic enhanced CT: a comparison of 5 and 10 min delays after intravenous contrast medium injection.
    Kumagae Y; Fukukura Y; Takumi K; Shindo T; Tateyama A; Kamiyama T; Kamimura K; Nakajo M
    Clin Radiol; 2013 Jul; 68(7):696-703. PubMed ID: 23482305
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differentiation of adrenal adenomas from nonadenomas using CT histogram analysis method: a prospective study.
    Halefoglu AM; Bas N; Yasar A; Basak M
    Eur J Radiol; 2010 Mar; 73(3):643-51. PubMed ID: 19167179
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Re: Evaluation of adrenal metastases from renal cell carcinoma and hepatocellular carcinoma: use of delayed contrast-enhanced CT.
    Siegel C
    J Urol; 2013 Dec; 190(6):2018-9. PubMed ID: 24209515
    [No Abstract]   [Full Text] [Related]  

  • 16. Distinguishing adrenal adenomas from nonadenomas: combined use of diagnostic parameters of unenhanced and short 5-minute dynamic enhanced CT protocol.
    Kamiyama T; Fukukura Y; Yoneyama T; Takumi K; Nakajo M
    Radiology; 2009 Feb; 250(2):474-81. PubMed ID: 19037020
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CT sensitivities for large (≥3 cm) adrenal adenoma and cortical carcinoma.
    Park SY; Park BK; Park JJ; Kim CK
    Abdom Imaging; 2015 Feb; 40(2):310-7. PubMed ID: 25060750
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adrenal masses: CT characterization with histogram analysis method.
    Bae KT; Fuangtharnthip P; Prasad SR; Joe BN; Heiken JP
    Radiology; 2003 Sep; 228(3):735-42. PubMed ID: 12954893
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Can established CT attenuation and washout criteria for adrenal adenoma accurately exclude pheochromocytoma?
    Patel J; Davenport MS; Cohan RH; Caoili EM
    AJR Am J Roentgenol; 2013 Jul; 201(1):122-7. PubMed ID: 23789665
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The value of 15-minute delayed contrast-enhanced CT to differentiate hyperattenuating adrenal masses compared with chemical shift MR imaging.
    Koo HJ; Choi HJ; Kim HJ; Kim SO; Cho KS
    Eur Radiol; 2014 Jun; 24(6):1410-20. PubMed ID: 24647823
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.